TEVA FY 2012 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$35B

FY 2012 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$20.3B+10.9% YoY

Gross Profit

$10.7B52.4% margin

Operating Income

$2.2B10.9% margin

Net Income

$2.0B9.7% margin

EPS (Diluted)

$2.25

Cash Flow

Operating Cash Flow

$4.6B

Free Cash Flow

$3.5B

Stock-Based Comp.

$82M

Balance Sheet

Total Assets

$50.6B

Total Liabilities

$27.7B

Stockholders' Equity

$22.8B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20.3B	$18.3B	+10.9%
Gross Profit	$10.7B	$9.5B	+11.9%
Operating Income	$2.2B	$3.1B	-29.1%
Net Income	$2.0B	$2.8B	-28.9%